Abstract
Summary
The objective is to analyse the evolution of the incidence of hip fracture in the female population of Spain from 2000 to 2012 and to establish the possible changes which may have been seen over this period of time, including the trends in the different regions of the country.
Introduction
Fragility-related hip fractures are considered to be the fractures of greatest significance to public health due to their high degree of morbidity and mortality. The change in their incidence, both in absolute values and when adjusted for age, is the subject of debate. The objective of this article is to describe the changes in the rates of hip fracture in Spain by autonomous community between the years 2000 and 2012.
Methods
Using the data from the Spanish Minimum Basic Data Set, in which are all the recorded cases of women with a principal diagnosis of hip fracture, the incidence rates by age group and by autonomous community were obtained. Poisson distribution or negative binomial regressions were carried out to estimate the average annual change over the time period analysed.
Results
There have been statistically significant changes in the trends of rates of incidence for all age groups of women over 65 years of age. The annual reduction was 2.2 % for women of 65–74 years of age and less for those between 75 and 84. The rates of incidence for those over 85 increased annually by 0.58 %.
Conclusions
Hip fractures continue to increase in absolute numbers, although if the rates are adjusted for age, a downward trend is seen in certain age groups. These findings have various origins, although in the absence of great changes in population structure, we believe that drug treatments for osteoporosis may play a role. There is variability in the change in incidence of hip fractures in different parts of the country. Further studies are required to be able to identify the causes.
Similar content being viewed by others
References
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475
Ivegard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Díez-Pérez A, Kanis JA (2013) Epidemiology and economic burden of osteoporosis in Spain. Arch Osteoporos 8(137):195–218
Auais M, Morin S, Nadeau L, Finch L, Mayo N (2013) Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada. Osteoporos Int 24:2713–2724
Hernández JL, Olmos JM, Alonso MA, González-Fernández CR, Martínez J, Pajarón M, Llorca J, González-Macías J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470
Leslie WD, O’Donell S, Jean S, Lagacé C, Walsh P, Bancej C, Morin S, Hanley DA, Papaoiannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889
Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of biphosphonates and hormone replacement therapy. Bone 45:246–253
Chevalley T, Guilley E, Hermann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40:1284–1289
Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905
Azagra R, López-Expósito F, Martín-Sánchez JC, Aquyé A, Moreno N, Cooper C, Díez-Pérez A, Dennison EM (2014) Changing trends in the epidemiology of hip fractures in Spain. Osteoporos Int 25:1267–74
Etxebarria-Foronda I, Mar J, Arrospide A, Esnal-Baza E (2010) Trends in the incidence of hip fractures in women in the Basque country. Arch Osteoporos 5:131–137
Melton LJ 3rd, Kanis JA, Johnell O (2005) Potential impact of osteoporosis treatment on hip fracture trends. J Bone Miner Res 20:895–897
Abrahamsen B, Vestergaard P (2010) Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int 21:373–380
Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419
Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921
Bernal-Delgado E, García Armesto S, Peiró S (2014) Atlas VPM group. Atlas of variations in medical practice in Spain: the Spanish National Health Service under scrutiny. Health Policy 114:15–30
Cameron AC, Trivedi PK (1988) Regression analysis of count data. Cambridge University Press, Cambridge
Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, Chandran M, Borgström F (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–92
Richards M (2010) Extent and causes of international variations in drug usage. A report for the secretary of state for health by Professor Sir Mike Richards CBE. Central Office of Information, Londres
Guerra-García MM, Rodriguez-Fernández JB, Puga-Sarmiento E, Charle-Crespo MA, Gomes Carvalho CS, Prejigueiro-Santás A (2011) Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain. Aten Primaria 43:82–8
Briongos L, Sañudo S, García-Alonso M, Ruiz-Mambrilla M, Dueñas-Laita A, Pérez-Castrillón JL (2013) Treatment of osteoporosis and hip fractures in a Spanish health area. Eur Rev Med Pharmacol Sci 17:266–8
Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305
Imaz I, Zegarra P, González-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor biphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943–51
de Felipe R, Cáceres C, Cimas M, Dávila G, Fernández S, Ruiz T (2010) Clinical characteristics of patients under treatment for osteoporosis in a primary care centre. Who do we treat? Aten Primaria 42:559–63
Lespessailles E, Cotté FE, Roux C, Fardellone P, Mercier F, Gaudin AF (2009) Incidence and features of osteoporosis in the French general population: the instant study. Joint Bone Spine 76:394–400
Cooper C, Eriksson JG, Forsén T, Osmond C, Tuomilehto J, Barker JP (2001) Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 12:623–629
Alonso-Franch M, Redondo Del Río MP, Suárez-Cortina L (2010) Nutrition and bone health in children. An Pediatr (Barc) 72:80.e1–11
Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086S
Arana-Arri E, Gutiérrez-Ibarlucea I, Ecenarro-Mugaguren A, Asua-Batarrita J (2007) Incidence of certain osteoporosis-determinig habits among post-menopausal women in the Basque country, Spain, in 2003. Rev Esp Salud Publica 81:647–656
Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29
Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162
Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willet WC, Newcomb PA (2006) From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 164:1003–1011
Navarro-Valverde C, Quesada-Gómez JM (2014) Deficiencia de vitamina D en España. ¿Realidad o mito? Rev Osteoporos Metab Miner 6(Supl 1):S5–10
García-Armesto S, Begoña Abadía-Taira M, Durán A, Hernández-Quevedo C, Bernal-Delgado E (2010) Spain: health system review. Health Syst Transit 12:1–295
Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M (2014) Multimorbidity patterns: a systematic review. J Clin Epidemiol 67:254–66
Mar J, Arrospide A, Comas M (2010) Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health 13:69–76
Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin. Results from the national registry of atrial Fibrilation 2. Arch Intern Med 166:241–246
Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59:781–786
Røste LS, Taubøll E (2007) Women and epilepsy: review and practical recommendations. Expert Rev Neurother 7:289–300
Salomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T (2009) A cohort study of thiazolidinediones and fractures in older adults with diabetes. J Clin Endocrinol Metab 94:2792–2798
Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE (2010) Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab 95:134–142
Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953
Khan MN, Khan AA (2008) Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol 15:S30–40
Warriner AH, Mugavero MJ (2010) Bone changes and fracture risk in individuals infected with HIV. Curr Rheumatol Rep 12:163–169
Olmos JM, Valero C, Del Barrio AG, Amado JA, Hernández JL, Menéndez-Arango J, González-Macías J (2010) Time course of bone loss in patients with anorexia nerviosa. Int Eat Disord 43:537–542
Stein E, Ebeling P, Shane E (2007) Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 36:937–963
Acknowledgments
We would like to acknowledge the editorial assistance provided by Andrew Stephens.
Conflicts of interest
Iñigo Etxebarria Foronda, Arantzazu Arróspide, Myrian Soto-Gordoa, José Ramón Caeiro, Luis Carlos Abecia and Javier Mar declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Etxebarria-Foronda, I., Arrospide, A., Soto-Gordoa, M. et al. Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012). Osteoporos Int 26, 1491–1497 (2015). https://doi.org/10.1007/s00198-014-3015-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-3015-8